Komori
Mochida Pharmaceutical (4534) · InitiativeRestated

Response Policy Concerning Large-Scale Purchase Actions

First written in FY2016. 15 of 20 entries say "Restated". Latest entry: FY2026.

20entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q2 – FY2019-Q3RestatedFY2020-Q1 – FY2021ReframedFY2022 – FY20252016: 320162017: 320172018: 420182019: 420192020: 220202021: 120212022: 120222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies
Takeover Defense Against Large-Scale PurchasesA theme 325 companies write about · 24 as a headwind · 230 as a tailwind

Mochida Pharmaceutical moved to the "Worse" side of this theme in 2022, 2 years before the typical company in this theme (2024).

79 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 181 companies compared. The sentences above are computed from all 181.Comparing 200 of the theme's 357 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「The response policy was effective from 27 June 2025 until the conclusion of the company's annual general meeting of shareholders scheduled for June 2028.」

    The company is reconfirming the response policy for large-scale purchases approved in June 2025 and its validity period through the conclusion of the June 2028 annual general meeting.
  2. FY2025ReframedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 27 June 2025, is as follows. The response policy was effective from 27 June 2025 until the conclusion of the company's annual general meeting of shareholders scheduled for June 2028.」

    With the expiration of the previous policy, the company changed to the new policy approved on 27 June 2025, extending the validity period through the conclusion of the June 2028 annual general meeting. In addition to the framework covering holdings of 20% or more of the voting rights, the policy covers concerted actions and establishes a special committee comprising independent outside members.
  3. FY2022ReframedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 29 June 2022, is as follows. The response policy was effective from 29 June 2022 until the conclusion of the company's annual general meeting of shareholders scheduled for June 2025.」

    With the expiration of the previous policy, a new response policy was approved and its validity period was renewed through the conclusion of the June 2025 annual general meeting. The framework covering holdings of 20% or more of the voting rights was maintained, while joint holdings and other relationships were added to its scope.
  4. FY2021RestatedAnnual report

    「The response policy was effective from 27 June 2019 until the conclusion of the company's annual general meeting of shareholders scheduled for June 2022.」

    The company is reconfirming the Large-Scale Purchase Rules covering holdings of 20% or more of the voting rights and their validity period through the conclusion of the annual general meeting of shareholders scheduled for June 2022.
  5. FY2020RestatedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 27 June 2019, is as follows.」

    The company is reconfirming the response policy for large-scale purchases covering holdings of 20% or more of the voting rights, with a validity period through the conclusion of the annual general meeting of shareholders scheduled for June 2022.
  6. FY2020-Q3RestatedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 27 June 2019, is as follows.」

    The company has reproduced the new response policy for large-scale purchases approved at the annual general meeting of shareholders held on 27 June 2019. It covers holdings of 20% or more of the voting rights, establishes procedures including a special committee, the provision of information and the Board of Directors' evaluation period, and remains valid through the conclusion of the annual general meeting of shareholders scheduled for June 2022.
  7. FY2020-Q2RestatedAnnual report

    「To ensure that shareholders are provided with the necessary and sufficient information in connection with a purchase of the company's shares or other securities (Note 3) intended to result in a specified shareholder group (Note 1) holding 20% or more of the voting rights (Note 2), or a purchase that would result in such a holding, the company's Board of Directors established the following rules concerning large-scale purchases (the "Large-Scale Purchase Rules").」

    The company has reproduced the new response policy for large-scale purchases approved at the annual general meeting of shareholders held on 27 June 2019. It covers holdings of 20% or more of the voting rights, establishes procedures including a special committee, the provision of information and the Board of Directors' evaluation period, and remains valid through the conclusion of the annual general meeting of shareholders scheduled for June 2022.
  8. FY2020-Q1RestatedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 27 June 2019, is as follows.」

    The company has reproduced the new response policy for large-scale purchases approved at the annual general meeting of shareholders held on 27 June 2019. It covers holdings of 20% or more of the voting rights, and its validity period runs through the conclusion of the annual general meeting of shareholders scheduled for June 2022.
  9. FY2019ReframedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 27 June 2019, is as follows.」

    With the expiration of the previous response policy, a new response policy was approved at the annual general meeting of shareholders held on 27 June 2019. Its validity period was set through the conclusion of the annual general meeting of shareholders scheduled for June 2022. The basic framework covering holdings of 20% or more of the voting rights was maintained.
  10. FY2019-Q3RestatedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 29 June 2016, is as follows. The response policy was effective from 29 June 2016 until the conclusion of the company's annual general meeting of shareholders scheduled for June 2019.」

    The company is reconfirming the response policy for large-scale purchases approved on 29 June 2016, procedures covering holdings of 20% or more of the voting rights, the special committee, and the validity period through the conclusion of the annual general meeting of shareholders scheduled for June 2019.
  11. FY2019-Q2RestatedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 29 June 2016, is as follows.」

    The company is reconfirming the Large-Scale Purchase Rules covering holdings of 20% or more of the voting rights, procedures including recommendations by the special committee, the provision of information and the Board of Directors' evaluation period, and the validity period through the conclusion of the annual general meeting of shareholders scheduled for June 2019.
  12. FY2019-Q1RestatedAnnual report

    「To ensure that shareholders are provided with the necessary and sufficient information in connection with a purchase of the company's shares or other securities intended to result in a specified shareholder group holding 20% or more of the voting rights, or a purchase that would result in such a holding, the company's Board of Directors established the following rules concerning large-scale purchases. The response policy was effective from 29 June 2016 until the conclusion of the company's annual general meeting of shareholders scheduled for June 2019.」

    The company is reconfirming the Large-Scale Purchase Rules covering holdings of 20% or more of the voting rights and their validity period through the conclusion of the annual general meeting of shareholders scheduled for June 2019.
  13. FY2018RestatedAnnual report

    「To ensure that shareholders are provided with the necessary and sufficient information in connection with a purchase of the company's shares or other securities intended to result in a specified shareholder group holding 20% or more of the voting rights, or a purchase that would result in such a holding, the company's Board of Directors established the following rules concerning large-scale purchases.」

    The company has reiterated the Large-Scale Purchase Rules covering holdings of 20% or more of the voting rights. The validity period runs through the conclusion of the annual general meeting of shareholders scheduled for June 2019.
  14. FY2018-Q3RestatedAnnual report

    「To ensure that shareholders are provided with the necessary and sufficient information in connection with a purchase of the company's shares or other securities (Note 3) intended to result in a specified shareholder group (Note 1) holding 20% or more of the voting rights (Note 2), or a purchase that would result in such a holding, the company's Board of Directors established the following rules concerning large-scale purchases. This applies except where the Board of Directors has given prior consent, regardless of the specific purchase method, including market transactions and tender offers. Such a purchase is referred to as a "large-scale purchase," and a person who conducts or intends to conduct one is referred to as a "large-scale purchaser." The rules are referred to below as the "Large-Scale Purchase Rules."」

    The company has reiterated the Large-Scale Purchase Rules covering holdings of 20% or more of the voting rights. The validity period runs through the conclusion of the annual general meeting of shareholders scheduled for June 2019.
  15. FY2018-Q2RestatedAnnual report

    「To ensure that shareholders are provided with the necessary and sufficient information in connection with a purchase of the company's shares or other securities intended to result in a specified shareholder group holding 20% or more of the voting rights, or a purchase that would result in such a holding, the company's Board of Directors established the following rules concerning large-scale purchases (the "Large-Scale Purchase Rules"). The response policy was effective from 29 June 2016 until the conclusion of the company's annual general meeting of shareholders scheduled for June 2019.」

    The company has reiterated the Large-Scale Purchase Rules covering holdings of 20% or more of the voting rights and their validity period through the conclusion of the annual general meeting of shareholders scheduled for June 2019.
  16. FY2018-Q1RestatedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 29 June 2016, is as follows.」

    The company has reproduced the response policy for large-scale purchases approved at the annual general meeting of shareholders held on 29 June 2016. The policy covers holdings of 20% or more of the voting rights and establishes procedures including a special committee, the provision of information and an evaluation period for the Board of Directors.
  17. FY2017-Q3RestatedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 29 June 2016, is as follows.」

    The company has reproduced in detail the response policy for large-scale purchases approved at the annual general meeting of shareholders. The policy covers holdings of 20% or more of the voting rights and establishes procedures including a special committee, the provision of information and an evaluation period for the Board of Directors.
  18. FY2017-Q2RestatedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 29 June 2016, is as follows.」

    The company has reproduced in detail the response policy for large-scale purchases approved at the annual general meeting of shareholders. The policy covers holdings of 20% or more of the voting rights and establishes procedures including a special committee, the provision of information and an evaluation period for the Board of Directors.
  19. FY2017-Q1AdvancedAnnual report

    「The following response policy, approved at the company's annual general meeting of shareholders held on 29 June 2016, is as follows.」

    The response policy for large-scale purchases was approved at the annual general meeting of shareholders held on 29 June 2016. The policy covers holdings of 20% or more of the voting rights and establishes procedures including a special committee, the provision of information and an evaluation period.
  20. FY2016First statedAnnual report

    「To ensure that shareholders are provided with the necessary and sufficient information in connection with a purchase of the company's shares or other securities intended to result in a specified shareholder group holding 20% or more of the voting rights, or a purchase that would result in such a holding, the company's Board of Directors established the following rules concerning large-scale purchases.」

    The rules were made effective from 29 June 2016 until the conclusion of the annual general meeting of shareholders scheduled for June 2019, and provided for a special committee, an evaluation period and other matters.
Moved together

"Sustainable Growth and Rebuilding the Earnings Structure" moved the same way as this thread, in the same document, in 3 of its 20 moves.

3332★1234
  1. ★This thread
  2. 1Sustainable Growth and Rebuilding the Earnings Structure3×
  3. 2Impact of Drug Cost Containment, Drug Price Revisions and Promotion of Generic Drugs3×
  4. 3Restoring Earnings Power Through Portfolio Restructuring and a Shift to New Drugs3×
  5. 4Securities Valuation Losses and Interest-Rate Risk2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Mochida Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Response Policy Concerning Large-Scale Purchase Actions | Mochida Pharmaceutical Co.,Ltd. (4534) | Komori